CollPlant Biotechnologies Ltd
0.2099 (3.11%)


Draw Mode:

Volume 9,450
Bid Price 6.75
Ask Price 7.29
News -
Day High 7.3299


52 Week Range


Day Low 6.60
Company Name Stock Ticker Symbol Market Type
CollPlant Biotechnologies Ltd CLGN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.2099 3.11% 6.95 14:14:31
Open Price Low Price High Price Close Price Prev Close
6.60 6.60 7.3299 6.7401
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
61 9,450 $ 7.11 $ 67,237 - 4.27 - 13.97
Last Trade Time Type Quantity Stock Price Currency
14:11:53 190 $ 6.95 USD

CollPlant Biotechnologies Ltd Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 68.91M 9.91M 9.91M $ 15.64M $ 181.44k -0.87 62.60
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - - -

more financials information »

CollPlant Biotechnologies News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No CLGN Message Board. Create One! See More Posts on CLGN Message Board See More Message Board Posts

Historical CLGN Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week7.898.41196.507.247,996-0.94-11.91%
1 Month10.0010.97946.508.649,794-3.05-30.5%
3 Months9.4513.976.5010.1215,917-2.50-26.46%
6 Months6.7613.974.278.3521,5800.192.81%
1 Year11.9213.974.278.4221,013-4.97-41.69%
3 Years8.5524.264.2713.9237,866-1.60-18.71%
5 Years7.5024.263.1312.8428,675-0.55-7.33%

CollPlant Biotechnologies Description

CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The company's revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing.